Amgen

Affymax Jumps Most in 16 Months on FDA Review of Anemia Drug
Bloomberg
Mon, 12/5/11 - 01:34 pm
Affymax
FDA
anemia
chronic kidney disease
JNJ
Amgen
peginesatide
December Catalysts for Drug and Biotech Stocks
Minyanville
Sat, 12/3/11 - 11:11 am
Pfizer
Aveo Pharmaceutical
Affymax
Amgen
Antares Pharma
Celgene
ONYX Pharmaceuticals
Seattle Genetics
Micromet
YM BioSciences
Regeneron
BioSante
5 Risky Biotechs With Serious Profit Potential
Seeking Alpha
Tue, 11/29/11 - 01:37 pm
Amgen
Gilead
Spectrum Pharmaceuticals
InterMune
ViroPharma
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
New Patent Could Be Worth $6 A Share To Amgen
Forbes
Mon, 11/28/11 - 09:55 am
Amgen
patents
Enbrel
rheumatoid arthritis
Looking back at Immunex and ahead to Seattle's biotech future
bizjournals.com
Sat, 11/26/11 - 10:15 am
Amgen
Amgen's new Enbrel patent could delay biosims for 17 years
Fierce Pharma
Wed, 11/23/11 - 01:11 pm
Enrbrel
Amgen
biosimilars
Merck
anti-inflammatory
Amgen Says It Signed Seven-Year Epogen Sales Agreement With DaVita
Bloomberg
Sat, 11/19/11 - 11:33 am
Amgen
DaVita
Epogen
Regeneron And Amgen: More Breakthrough Drugs On The Horizon
Seeking Alpha
Fri, 11/18/11 - 11:45 am
Amgen
Regeneron
AMG145
PCSK9 inhibitor
Has Amgen crossed into Big Pharma territory?
Fierce Pharma
Mon, 11/14/11 - 05:20 pm
Amgen
Big Pharma
Let's Check Amgen's Growth
Motley Fool
Sun, 11/13/11 - 12:07 pm
Amgen
Amgen To Trade Ex-Dividend
Forbes
Sat, 11/12/11 - 12:19 pm
Amgen
U.S. court allows class action suit against Amgen
Reuters
Wed, 11/9/11 - 12:08 pm
Class Action Lawsuit
Amgen
Amgen Stock Rises on New Buyback Plan, But How About the Debt?
Barron's
Mon, 11/7/11 - 09:13 pm
Amgen
debt
stock buyback
Amgen jumps 5% on $5 billion stock buy-back
Marketwatch
Mon, 11/7/11 - 11:55 am
Amgen
stock buyback
Treatment With Enbrel® (etanercept) Shows Significant and Sustained Clinical Benefits in Rheumatoid Arthritis (RA) Patients With Moderately Active Disease
Yahoo/PR NewsWire
Sun, 11/6/11 - 12:01 pm
Enbrel
Amgen
rheumatoid arthritis
Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial
Yahoo/PR NewsWire
Sun, 11/6/11 - 12:00 pm
Prolia
osteoporosis
Amgen
Amgen Is A Bargain At These Levels
Seeking Alpha
Thu, 11/3/11 - 12:33 pm
Amgen
1 Reason the Street Should Love Amgen's Earnings
Motley Fool
Mon, 10/31/11 - 11:28 am
earnings
Amgen
Amgen Is Poised For Continued Success
Seeking Alpha
Wed, 10/26/11 - 09:08 am
Amgen
Pharmasset
Dendreon

Pages